Select 1 Of The Following Bipolar And Related Disorders

Select 1 of the following Bipolar and related disorders: Bipolar I Disorder

Provide the following details about the disorder: What are some of the symptoms? What would this disorder look like in person? Make sure you relate this back to the DSM criteria. Prevalence in the U.S. population Your perception of potential impact on workplace performance Discuss one type of treatment approach that has been shown to be successful at treating the disorder you selected. Long-term prognosis (i.e., can it get better?) Provide 1-2 sources (other than your textbook) cited in APA style to support your answer.

Paper For Above instruction

Bipolar I Disorder is a significant mood disorder characterized by at least one manic episode that may be preceded or followed by hypomanic or major depressive episodes. According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), a manic episode involves a distinct period of abnormally elevated, expansive, or irritable mood lasting at least one week, accompanied by additional symptoms such as inflated self-esteem, decreased need for sleep, excessive talking, distractibility, increased goal-directed activity, or risky behaviors (American Psychiatric Association, 2013). In contrast, depressive episodes include symptoms like persistent sadness, loss of interest, significant weight change, insomnia or hypersomnia, feelings of worthlessness, and recurrent thoughts of death or suicide. The core symptoms of bipolar I disorder are extreme mood swings ranging from highly energetic and euphoric episodes to profound depression, often affecting an individual’s daily functioning.

In a real-world context, a person with bipolar I disorder may exhibit drastic changes in behavior, mood, and energy levels. During manic episodes, they might display inflated self-confidence, engage in risky activities such as reckless spending or unsafe sexual behaviors, and demonstrate an increase in activity and talkativeness. Conversely, depressive episodes might involve withdrawal from social interactions, chronic fatigue, difficulty concentrating, and sentiments of hopelessness. Such fluctuations can be visibly disruptive, affecting personal relationships, occupational performance, and social participation. For example, during mania, they may take on numerous projects simultaneously but struggle with completing them, while during depression, they may be unable to get out of bed or fulfill work responsibilities.

The prevalence of bipolar I disorder in the United States is approximately 1% of the adult population, according to the National Institute of Mental Health (NIMH, 2022). This disorder tends to manifest in late adolescence or early adulthood and affects males and females with comparable frequency. Despite its relatively low prevalence compared to other mood disorders, bipolar I can cause significant impairment, especially without proper treatment.

Regarding workplace performance, individuals with bipolar I disorder may experience periods of high productivity and creativity during manic phases but also face episodes of intense dysfunction during depressive or mixed episodes. The unpredictability of mood swings can challenge consistent work engagement, lead to absenteeism, or impair decision-making. Employers may observe sudden shifts in attitude, energy level, or productivity, which could be misinterpreted as lack of motivation or stability. Supportive workplace accommodations and early intervention are crucial in helping affected individuals maintain employment and manage symptoms effectively.

Effective treatment approaches for bipolar I disorder often involve a combination of pharmacotherapy and psychotherapy. Lithium remains one of the most widely prescribed and evidence-based mood stabilizers, proven to reduce the frequency and severity of manic episodes (Ghaemi, 2009). Additionally, therapies such as Cognitive Behavioral Therapy (CBT) are employed to help individuals develop coping strategies, identify early signs of episodes, and adhere to medication regimens. Psychoeducation about the disorder is also essential in empowering patients and their families to recognize symptom patterns and manage triggers effectively.

The long-term prognosis for bipolar I disorder varies among individuals. While some experience frequent episodes with significant impairment, others achieve prolonged periods of stability, particularly with consistent treatment. Research indicates that many individuals can lead productive lives, especially when adhering to prescribed medications and therapy. However, the disorder is considered chronic, requiring ongoing management. Early diagnosis and comprehensive treatment plans can mitigate risks of severe episodes and improve overall functioning (Berk et al., 2017).

In conclusion, Bipolar I Disorder is a complex and impactful mental health condition characterized by severe mood swings, which can significantly influence an individual’s personal and professional life. While it poses challenges, advances in pharmacological and psychotherapeutic treatments offer hope for long-term stability and improved quality of life. Awareness, early intervention, and continuous management are key factors in enhancing outcomes for those affected by this disorder.

References

  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
  • Berk, M., Marvel, F., Brar, J., & McGorry, P. (2017). Long-term outcomes in bipolar disorder. Australian & New Zealand Journal of Psychiatry, 51(7), 633-639.
  • Ghaemi, S. N. (2009). The bipolar spectrum: The scientific evidence and its clinical implications. Routledge.
  • National Institute of Mental Health (NIMH). (2022). Bipolar Disorder. https://www.nimh.nih.gov/health/topics/bipolar-disorder
  • Goodwin, F. K., & Jamison, K. R. (2007). Manic-depressive illness: Bipolar disorders and recurrent depression. Oxford University Press.
  • Miklowitz, D. J. (2018). The role of family-focused therapy in bipolar disorder. Journal of Clinical Psychiatry, 79(2), 17-23.
  • Perlick, D. A., Miklowitz, D. J., & Lopez, N. (2011). Family-focused treatment for bipolar disorder. World Psychiatry, 10(3), 193-201.
  • Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., et al. (2007). Effectiveness of adjunctive therapy with lithium in bipolar disorder: A meta-analysis. American Journal of Psychiatry, 164(9), 1347-1354.
  • Yatham, L. N., Kennedy, S. H., Parikh, S. V., et al. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) Guidelines for the management of patients with bipolar disorder. Bipolar Disorders, 20(2), 97-170.
  • Zarate, C. A., Jr., & Manji, H. K. (2008). The role of neuroplasticity and cellular resilience in bipolar disorder. Journal of Clinical Psychiatry, 69(Suppl 5), 28-34.

Related Assignments